This document summarizes information about the drug Livalo (pitavastatin), including its indications, mechanism of action, pharmacokinetics, dosage and administration, drug interactions, warnings, and clinical trial results. Livalo is a statin approved to reduce cholesterol levels and treat hyperlipidemia. It works by inhibiting the HMG-CoA reductase enzyme in the liver to decrease cholesterol synthesis. Clinical trials demonstrated Livalo to be effective at reducing LDL-C, total cholesterol, and triglycerides and increasing HDL-C compared to other statins like atorvastatin, simvastatin, and pravastatin.